Interim Clinical-Trial Data Boosts Bio-Path (BPTH) Shares
After a presentation of interim clinical trial data, shares of Bio-Path Holdings, Inc. (NASDAQ: BPTH) have seen a notable increase. BPTH shares increased by 15.44% to $2.31 as of the most recent market check. Presentation Of Interim Results In order to treat acute myeloid leukemia, or AML, Bio-Path (BPTH) revealed preliminary results from their Phase […]